Estimating the risk of re-emergence after stopping polio vaccination.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 3390584)

Published in Front Microbiol on May 21, 2012

Authors

Akira Sasaki1, Yoshihiro Haraguchi, Hiromu Yoshida

Author Affiliations

1: Department of Evolutionary Studies of Biosystems, The Graduate University for Advanced Studies Hayama, Kanagawa, Japan.

Articles citing this

Genomics and computational science for virus research. Front Microbiol (2013) 0.77

Articles cited by this

Directly transmitted infections diseases: control by vaccination. Science (1982) 5.72

Antigenic diversity thresholds and the development of AIDS. Science (1991) 5.13

Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan. Lancet (2000) 3.20

Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. Am J Epidemiol (1999) 3.16

Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis (1992) 3.07

Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci U S A (1997) 2.58

Trial of a supplemental dose of four poliovirus vaccines. N Engl J Med (2000) 2.35

Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol (1998) 2.24

Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis (1997) 2.16

Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis (2011) 2.14

Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ (2000) 2.00

Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines. J Infect Dis (2006) 1.98

Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland. Appl Environ Microbiol (1988) 1.94

The molecular biology of poliovaccines. J Gen Virol (1992) 1.75

Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter. Am J Epidemiol (1967) 1.55

A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine. J Hyg (Lond) (1966) 1.51

Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J Clin Microbiol (2000) 1.50

Evolution of antigen drift/switching: continuously evading pathogens. J Theor Biol (1994) 1.40

Vaccination, evolution and changes in the efficacy of vaccines: a theoretical framework. Proc Biol Sci (1995) 1.29

Circulation of a type 2 vaccine-derived poliovirus--Egypt, 1982-1993. MMWR Morb Mortal Wkly Rep (2001) 1.23

Inactivated poliovirus vaccine: past and present experience. Vaccine (1996) 1.22

Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources. J Med Virol (1990) 1.22

Outbreaks of paralytic poliomyelitis, 1976-1995. J Infect Dis (1997) 1.20

N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152. Virology (1989) 1.15

Mathematical biology of HIV infections: antigenic variation and diversity threshold. Math Biosci (1991) 1.14

Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants. Vaccine (1997) 1.09

Interrupting the transmission of wild polioviruses with vaccines: immunological considerations. Bull World Health Organ (1994) 1.08

Antigenic analysis of polioviruses isolated from a child with agammaglobulinemia and paralytic poliomyelitis after Sabin vaccine administration. Microbiol Immunol (1981) 1.06

Evolutionary pattern of intra-host pathogen antigenic drift: effect of cross-reactivity in immune response. Philos Trans R Soc Lond B Biol Sci (1997) 1.05

Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated? Am J Epidemiol (1996) 1.01

Outbreak of poliomyelitis--Dominican Republic and Haiti, 2000. MMWR Morb Mortal Wkly Rep (2000) 0.95

Assessment of poliovirus eradication in Japan: genomic analysis of polioviruses isolated from river water and sewage in toyama prefecture. Appl Environ Microbiol (2000) 0.93

Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine. J Infect Dis (1993) 0.91

Shedding of sabin poliovirus Type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine. J Infect Dis (2004) 0.90

Primary immunodeficiency diseases. Report of a WHO sponsored meeting. Immunodefic Rev (1989) 0.86

Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains. J Med Virol (2005) 0.84

Antigenic drift of viruses within a host: a finite site model with demographic stochasticity. J Mol Evol (2000) 0.83

Evaluation of Sabin live poliovirus vaccine in Japan. II. Clinical, virologic and immunologic effects of vaccine in children. Jpn J Med Sci Biol (1966) 0.82

Presence of polioviruses and other enteral viruses in sewage: a survey in the Czech Socialistic Republic 1969-1976. J Hyg Epidemiol Microbiol Immunol (1982) 0.81

Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan. Scand J Infect Dis (2007) 0.81

Poliomyelitis prevention: revised recommendations for use of inactivated and live oral poliovirus vaccines. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics (1999) 0.80

Poliovirus surveillance: isolation of polioviruses in Japan, 1980-1991. A report of the National Epidemiological Surveillance of Infectious Agents in Japan. Jpn J Med Sci Biol (1992) 0.80

Evaluation of Sabin live poliovirus vaccine in Japan. IV. Marker tests on poliovirus strains recovered from vaccinees and their contacts. Jpn J Med Sci Biol (1967) 0.77

Deterministic models for the eradication of poliomyelitis: vaccination with the inactivated (IPV) and attenuated (OPV) polio virus vaccine. Math Biosci (1995) 0.77

Articles by these authors

Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011. Emerg Infect Dis (2012) 2.26

Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol (2004) 1.55

Molecular typing and epidemiology of non-polio enteroviruses isolated from Yunnan Province, the People's Republic of China. J Med Virol (2008) 1.34

A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol (2005) 1.23

An enterovirus 71 epidemic in Guangdong Province of China, 2008: epidemiological, clinical, and virogenic manifestations. Jpn J Infect Dis (2011) 1.19

A comparison of the VP1, VP2, and VP4 regions for molecular typing of human enteroviruses. J Med Virol (2010) 1.12

Cocirculation of two transmission lineages of echovirus 6 in jinan, china, as revealed by environmental surveillance and sequence analysis. Appl Environ Microbiol (2011) 1.11

Molecular epidemiology of echoviruses 11 and 13, based on an environmental surveillance conducted in Toyama Prefecture, 2002-2003. Appl Environ Microbiol (2006) 1.06

Viral gastroenteritis in Mongolian infants. Emerg Infect Dis (2005) 1.03

Isolation of a recombinant type 3/type 2 poliovirus with a chimeric capsid VP1 from sewage in Shandong, China. Virus Res (2010) 0.98

Intercity spread of echovirus 6 in Shandong Province, China: application of environmental surveillance in tracing circulating enteroviruses. Appl Environ Microbiol (2012) 0.96

Development of a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) system for a highly sensitive detection of enterovirus in the stool samples of acute flaccid paralysis cases. BMC Infect Dis (2009) 0.92

Prevalence of nonpolio enteroviruses in the sewage of Guangzhou city, China, from 2009 to 2012. Appl Environ Microbiol (2013) 0.86

Environmental surveillance of human enteroviruses in Shandong Province, China, 2008 to 2012: serotypes, temporal fluctuation, and molecular epidemiology. Appl Environ Microbiol (2014) 0.86

Phylogenetic and molecular characterization of coxsackievirus A24 variant isolates from a 2010 acute hemorrhagic conjunctivitis outbreak in Guangdong, China. Virol J (2012) 0.85

An optimized method for elution of enteroviral RNA from a cellulose-based substrate. J Virol Methods (2012) 0.84

Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan. Scand J Infect Dis (2007) 0.81

Neurovirulence of type 1 polioviruses isolated from sewage in Japan. Appl Environ Microbiol (2002) 0.81

Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan. J Med Virol (2002) 0.80

Identification and characterization of two strains of human parechovirus 4 isolated from two clinical cases in Fukuoka City, Japan. J Clin Microbiol (2008) 0.80

Molecular evolution of VP3, VP1, 3C(pro) and 3D(pol) coding regions in coxsackievirus group A type 24 variant isolates from acute hemorrhagic conjunctivitis in 2011 in Okinawa, Japan. Microbiol Immunol (2014) 0.79

Development of real-time PCR to detect oral vaccine-like poliovirus and its application to environmental surveillance. J Virol Methods (2013) 0.79

Endemic transmission of echovirus 30 in Toyama, Japan in 2010 is verified by environmental surveillance. Jpn J Infect Dis (2011) 0.79

Evaluating the prevalence and molecular epidemiology of echovirus 11 isolated from sewage in Shandong Province, China in 2010. Virus Genes (2012) 0.78

Intrafamilial transmission of a Sabin 1-related poliovirus in Shizuoka Prefecture, Japan. Jpn J Infect Dis (2006) 0.77

Measles outbreak after a post-honeymoon period in Mongolia, 2001. Jpn J Infect Dis (2007) 0.77

[Epidemiological surveillance for viral pollution of rivers in Toyama Prefecture]. Nihon Koshu Eisei Zasshi (2007) 0.77

Molecular detection of hepatitis E virus in rivers in the Philippines. Am J Trop Med Hyg (2014) 0.76

[The first report of an epidemic of human metapneumovirus infection in Japan: clinical and epidemiological study]. Kansenshogaku Zasshi (2004) 0.76

Widespread circulation of echovirus type 13 demonstrated by increased seroprevalence in Toyama, Japan, between 2000 and 2003. Clin Vaccine Immunol (2010) 0.76

Keratoconjunctivitis caused by echovirus type 13 in Japanese children. Pediatr Infect Dis J (2003) 0.75

Detection of dual-infected cases of adenoviruses and coxsackieviruses type B by real-time PCR but not by the conventional viral culture technique. Clin Lab (2007) 0.75

Surveillance of poliovirus-isolates in Japan, 2002. Jpn J Infect Dis (2003) 0.75

[Influence of genome extraction kits on enterovirus detection using RT-PCR]. Kansenshogaku Zasshi (2008) 0.75

Neutralization assays for echovirus 18 isolates in 2006. Jpn J Infect Dis (2007) 0.75